BCL2 and hepatocellular carcinoma: Our results showed that HCC group was four-folds lower in miR-139-5p expression level, which targets IGF1R, MET, and BCL2 that regulate the MAPK signaling pathway, apoptosis, and mTOR signaling pathway.